The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Stoke Therapeutics Inc (NASDAQ: STOK) was $13.76 for the day, up 3.69% from the previous closing price of $13.27. In other words, the price has increased by $3.69 from its previous closing price. On the day, 0.83 million shares were traded. STOK stock price reached its highest trading level at $14.3 during the session, while it also had its lowest trading level at $12.99.
Ratios:
Our analysis of STOK’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.09 and its Current Ratio is at 5.09. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 09 ’24 when JONATHAN ALLAN bought 12,114 shares for $13.27 per share.
Ticho Barry sold 10,000 shares of STOK for $120,698 on Dec 02 ’24. The CHIEF MEDICAL OFFICER now owns 51,277 shares after completing the transaction at $12.07 per share. On Nov 01 ’24, another insider, Ticho Barry, who serves as the CHIEF MEDICAL OFFICER of the company, sold 10,000 shares for $12.68 each. As a result, the insider received 126,803 and left with 2,485 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STOK now has a Market Capitalization of 728825920 and an Enterprise Value of 495461280. For the stock, the TTM Price-to-Sale (P/S) ratio is 45.96 while its Price-to-Book (P/B) ratio in mrq is 3.14. Its current Enterprise Value per Revenue stands at 29.592 whereas that against EBITDA is -4.307.
Stock Price History:
Over the past 52 weeks, STOK has reached a high of $17.58, while it has fallen to a 52-week low of $4.09. The 50-Day Moving Average of the stock is 10.53%, while the 200-Day Moving Average is calculated to be 7.88%.
Shares Statistics:
STOK traded an average of 595.92K shares per day over the past three months and 685650 shares per day over the past ten days. A total of 52.94M shares are outstanding, with a floating share count of 41.02M. Insiders hold about 22.56% of the company’s shares, while institutions hold 92.35% stake in the company. Shares short for STOK as of 1731628800 were 6403252 with a Short Ratio of 10.75, compared to 1728950400 on 6786785. Therefore, it implies a Short% of Shares Outstanding of 6403252 and a Short% of Float of 18.049999.
